Morse E E, Katz A J, Buchholz D H, Houx J
Cancer. 1981 Mar 1;47(5):974-7. doi: 10.1002/1097-0142(19810301)47:5<974::aid-cncr2820470525>3.0.co;2-x.
Clinical effectiveness of granulocyte transfusions collected by filtration or by intermittent flow centrifugation was compared in this study. In 251 patients receiving at least four daily transfusions of these products, there was no difference in response rate (67% in each group) as determined by defervescence. The most important factor in the recovery of patients appeared to be the underlying disease causing the agranulocytosis. Patients whose marrows were temporarily suppressed by chemotherapy showed the highest recovery rates (82% lymphoma and carcinoma), whereas those with intrinsic disease in the marrow showed the lowest recovery rates (47% aplastic anemia, 63% acute leukemia).
本研究比较了通过过滤或间歇流离心法采集的粒细胞输注的临床效果。在251例接受这些产品至少每日4次输注的患者中,通过退热确定的反应率无差异(每组均为67%)。患者恢复的最重要因素似乎是导致粒细胞缺乏症的基础疾病。骨髓被化疗暂时抑制的患者显示出最高的恢复率(淋巴瘤和癌为82%),而骨髓存在内在疾病的患者恢复率最低(再生障碍性贫血为47%,急性白血病为63%)。